FitLife Brands 3Q 2026: Revenue $25.62M, EPS $0.16 — 10-Q Summary

FitLife Brands reported 3Q 2026 revenue of $25.62M, up 9% YoY, and net income of $1.57M, up 71% YoY. Growth was driven by Irwin operations and lower costs, while Legacy FitLife saw revenue decline. The company recorded $280K in restructuring costs but expects $1.2M in annual savings starting 4Q 2026.

Original reporting
Published Nov 16, 2026, 12:41 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 16, 2026, 12:47 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
FitLife Brands 3Q 2026: Revenue $25.62M, EPS $0.16 — 10-Q Summary — source image
Decision brief

The 30-second read

$FTLFBullishLow
01

Why it matters

The earnings beat may attract short‑term buying interest, but the modest scale limits broader market moves.

02

Market read

Micro‑cap earnings release with modest upside potential; limited impact beyond niche sector.

03

What to watch

Restructuring costs and lower gross profit from Legacy FitLife could offset gains if not managed.

Relevance 6/10Novelty 6/10Timing: post‑market today

Background

FitLife Brands, a publicly traded health‑and‑wellness company, filed its Q3 2026 10‑Q with improved financial metrics.

Company-level read

Ticker impact

$FTLFBullishHigh confidence
Context

FitLife Brands reported Q3 2026 revenue of $25.62M and EPS of $0.16 in its 10‑Q filing.

Expected impact

likely modest upside as investors price in higher earnings and lower tax rate

Evidence & confidence

The 10‑Q is the first public disclosure of these numbers; the 9% revenue rise and 71% net income increase are material for a micro‑cap.

Market effects

Shows strength in the health‑and‑wellness niche, may lift peer small‑cap supplement firms.

Limited to U.S. micro‑cap segment.

Minimal global impact.

Counterpoint

The revenue boost is driven by a single segment (Irwin) and may not be sustainable; legacy brand weakness could pressure the stock.

Key entities

  • FitLife Brands, Inc.

    Issuer of the 10‑Q filing.

Related articles

$FTLFMed

FitLife Brands (FTLF) Q2 2026 Earnings Call Transcript

FitLife Brands (FTLF) reported Q2 2026 earnings. Legacy FitLife's gross margin rose to 41.7%, but contribution fell 25.9% to $4.2M. Irwin's revenue hit $14.1M, with Amazon sales growing. The company is improving supply chain, product development, and marketing. SG&A costs dropped 3.8% sequentially. The term loan balance is $36.1M, with $8.6M of debt paid since the Irwin acquisition.

$FTLFMed

FitLife Brands Q2 Earnings Call Highlights

FitLife Brands (NASDAQ:FTLF) reported Q2 call highlights. Irwin direct Amazon sales rose from about $500k monthly in Dec 2025 to about $1m in June 2026, with July comparable to June. Legacy revenue fell 23% YoY to $12.4m; gross margin 41.7%. FitLife is extending Irwin shelf life and launching new products. It paid about $1.5m term-loan, cutting term-loan to $36.1m.

$FTLFMed

FitLife Brands Announces Second Quarter 2026 Results

FITLIFE BRANDS, INC. (FTLF) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 FitLife Brands Announces Second Quarter 2026 Results OMAHA, NE – August 13, 2026 – FitLife Brands, Inc. (“ FitLife ” or the “ Company ”) (NASDAQ: FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced financial

$GPROMed

GoPro year-over-year Q3 revenue declines 41%

GoPro reported Q3 revenue of $96.2M, down 41% YoY, and a net loss of $48M. The company delayed its earnings report due to merger-related financial procedures. The merger with Starman Optical, announced in September, is still on track, with the closing deadline extended to March 2027. GoPro will not provide financial guidance due to the pending transaction.